| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Duato Joaquin | CEO and Chairman of the Board, Director | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK | /s/ Joleen Morgan, as attorney-in-fact for Joaquin Duato | 28 Jan 2026 | 0001673401 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JNJ | Common Stock | Sale | $11,318,461 | -51,218 | -39% | $220.99 | 79,634 | 26 Jan 2026 | By spouse | F1 |
| transaction | JNJ | Common Stock | Sale | $10,804,432 | -48,782 | -61% | $221.48 | 30,852 | 26 Jan 2026 | By spouse | F2 |
| holding | JNJ | Common Stock | 275,967 | 26 Jan 2026 | Direct | ||||||
| holding | JNJ | Common Stock | 988 | 26 Jan 2026 | By 401k | F3 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $220.39 to $221.376. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | This transaction was executed in multiple trades at prices ranging from $221.38 to $221.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2025). |